Sarparast A

School of Medicine, Oregon Health and Science University, Portland, OR, United States.

2 papers · 4 preprints · ORCID

ArticlePsilocybin

Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation service.

Harrison HV, Gaillard M, Cook RR +2

Europe PMC2026
PreprintPsilocybin

Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases

Sarvi M, Lucas W, Levander X +1

Europe PMC2026
PreprintPsilocybin

Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases

Sarvi M, Sarparast A

Europe PMC2026
PreprintPsilocybin

Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation service

Harrison HV, Gaillard M, Cook RR +2

Europe PMC2026
PreprintMDMA

MDMA-Assisted Therapy for Social Anxiety Disorder: A Randomized, Open-label, Wait-list Controlled Trial

Luoma JB, Lear MK, Pilecki B +9

Europe PMC2026
ArticlePsilocybin

Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.

Sarparast A, Thomas K, Malcolm B +1

Europe PMC2022